Finance

Lists
CLPT:NASDAQ
Clearpoint Neuro Inc
$13.15
0.00%
(0.00) 1D
$13.35
+1.52% (+0.20)
Pre-market
Closed: Sep 15, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CLPT...
Open
$13.45
High
$13.50
Low
$12.99
Mkt. cap
401.13M
Avg. vol.
632.22K
Volume
502.00
52-wk high
$30.10
52-wk low
$8.27
EPS
-$1.18
Beta
1.26
Shares outstanding
30.50M
No. of employees
172
Open
$13.45
High
$13.50
Low
$12.99
Mkt. cap
401.13M
Avg. vol.
632.22K
Volume
502.00
52-wk high
$30.10
52-wk low
$8.27
EPS
-$1.18
Beta
1.26
Shares outstanding
30.50M
No. of employees
172
News stories
From web sources and news partners
About Clearpoint Neuro Inc
CEOJoseph M. Burnett
Employees172
Founded1998
HeadquartersSolana Beach, California, United States
SectorMedical device
Websiteclearpointneuro.com
Analyst ratings
Based on 3 analysts giving stock ratings to CLPT in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for CLPT in the last 3 months.
Highest
Current $13.15
$30.00 (+128.14%)
Average
$27.50 (+109.13%)
Lowest
$25.00 (+90.11%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Stephan
Stifel Nicolaus
Buy
Reiterated
-
-
09/15/2026
Frank Takkinen
Lake Street
Buy
Reiterated
$25.00
+90.1%
09/03/2026
Anderson Schock
B. Riley Securities
Buy
Maintained
$30.00
+128.1%
06/17/2026
Chad Messer
Lake Street
Buy
Reiterated
$30.00
+128.1%
05/14/2026
Thomas Flaten
Lake Street
Buy
Reiterated
$30.00
+128.1%
04/21/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
8.86M
10.41M
12.13M
10.88M
Cost of goods sold
3.26M
4.01M
4.37M
4.17M
Cost of revenue
3.26M
4.01M
4.37M
4.17M
Research and development expenses
3.45M
3.24M
4.52M
4.63M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.42M
8.41M
11.71M
12.32M
Operating expense
10.88M
11.65M
16.23M
16.95M
Total operating expenses
14.14M
15.66M
20.61M
21.12M
Operating income
-5.28M
-5.24M
-8.48M
-10.24M
Other non operating income
-64.00K
-34.00K
-35.00K
-7.00K
EBT including unusual items
-5.88M
-7.78M
-9.54M
-11.38M
EBT excluding unusual items
-5.88M
-5.98M
-9.54M
-11.38M
Income tax expense
8.00K
4.00K
8.00K
-38.00K
Effective tax rate
-0.14%
-0.05%
-0.08%
0.33%
Other operating expenses
-
-
-
-
Net income
-5.89M
-7.79M
-9.55M
-11.34M
Net profit margin
-66.48%
-74.79%
-78.76%
-104.20%
Earnings per share
-0.21
-0.27
-0.32
-0.38
Interest and investment income
357.00K
385.00K
351.00K
289.00K
Interest expense
-900.00K
-1.09M
-1.38M
-1.41M
Net interest expenses
-543.00K
-703.00K
-1.03M
-1.12M
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.21M
-4.93M
-8.18M
-9.89M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps